Robert J. Bitterman - 10 Jun 2025 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Signature
/s/ Robert J. Bitterman
Issuer symbol
PHIO
Transactions as of
10 Jun 2025
Net transactions value
+$4,840
Form type
4
Filing time
11 Jun 2025, 17:00:01 UTC
Previous filing
10 Jun 2025
Next filing
15 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bitterman Robert J Chairman, Pres & CEO, Director C/O PHIO PHARMACEUTICALS CORP., 11 APEX DR., SUITE 300A, PMB 2006, MARLBOROUGH /s/ Robert J. Bitterman 11 Jun 2025 0001304395

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common Stock, $0.0001 par value Purchase $4,840 +2,000 +8% $2.42 27,149 10 Jun 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.